Smoking Linked to Cognitive Decline in Children: Study

Aug.31.2022
Smoking Linked to Cognitive Decline in Children: Study
Smoking linked to poor cognitive performance and brain volume reduction in children, per a 2-year study on 1000+ children in Nebraska, US.

A study conducted in the state of Nebraska, United States revealed that smoking is associated with poor cognitive performance and reduced brain volume among more than 1,000 children aged 9 to 10 years old who were followed up for two years. The study found that the effects of smoking could have a lasting impact.


Among those investigated, 116 children reported using tobacco products and were considered to be the earliest group of tobacco users in the study. This group performed poorly on the tests (mean, b = -2.9; SE, 0.6; P <.001), showing lower crystallized cognitive composite scores (b = -2.4; SE, 0.5; P <.001) and total cognitive composite scores (b = -2.9; SE, 0.5; P = .01). In a follow-up study of two years, smokers had lower cortical volumes in the frontal, parietal, and temporal lobes than non-users.


According to a report by Dr. Hongying Daisy Dai, Chief Researcher at the University of Nebraska Medical Center, electronic cigarettes and smokeless tobacco products should not be considered as a substitute to traditional cigarettes for youth to reduce tobacco-related harm. Authorities should implement comprehensive intervention strategies and tobacco control policies to prevent tobacco initiation.


From October 2016 to October 2018, a study titled Adolescent Brain Cognitive Development (ABCD) included 11,729 children from 21 US-based websites. This study followed up with the participants from August 2018 to January 2021. Participants were asked to complete a survey about tobacco use, including e-cigarettes, cigarettes, cigars, smokeless tobacco, hookah, pipes, and nicotine replacement products.


Dai and colleagues utilized a comprehensive combination of cognitive assessment measures, including the National Institutes of Health Toolbox Cognitive Battery, morphometric analysis, and structural MRI, to evaluate differences between users and non-users. In terms of race and ethnicity, 2.1% of the sample were Asian; 20.3% were Hispanic/Latino; 14.9% were non-Hispanic Black; and 52.1% were non-Hispanic White. Just over a quarter (27.3%) of the sample had parents who were college graduates, and 13.7% had parents with an annual income less than $25,000.


During a two-year follow-up period, the scores of first-time tobacco users in oral recognition (b=-2.1; SE, 0.5; P<.001), picture sequencing memory (b=-3.0; SE, 0.7; P<.001), and crystallized cognitive composite scores (b=-2.7; SE, 0.8; P=.005) remained lower than non-users. In SMRI analysis, former smokers exhibited significantly decreased measurements in the entire brain, including the total cortical surface area in the first wave (b=-5014.8 mm3; SE, 7043.9; P=.002), total cortical volume in the first wave (b=-174,621.0 mm3; SE, 5857.7; P=.003) and follow-up (b=-21,790.8 mm3; SE, 7043.9; P=.002), and total intracranial volume in the first wave (b=-38,442.8 mm3; SE, 12,057.7; P=.009).


In a related editorial, Dr. Laviolette from the University of Western Ontario wrote, "The findings reported by Dai and colleagues raise many important questions for future clinical and preclinical investigations. It is important to determine the extent to which these pathophysiological findings extend beyond the window of brain maturation prior to adolescence. Furthermore, it is crucial to identify the specific molecular mechanisms and biomarkers underlying these persistent tobacco-induced pathophysiological effects.


He added that the description of potential mechanisms could facilitate similar identification of intervention and reversal strategies for "neurological and psychiatric phenotypes caused by nicotine exposure in children, adolescents, and even prenatal exposure." Additionally, advances in genomic and transcriptomic analysis could better understand the potential genetic factors that could make individuals more susceptible to nicotine products during critical periods of brain development, as well as factors that could increase the risk of serious neurological and cognitive outcomes after exposure to nicotine during the developmental window for some individuals.


Statement: 1. This article's content is based on the compilation of third-party information and is intended solely for industry exchanges and learning purposes. 2. The views expressed in this article do not represent those of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The compilation of this article is for industry exchange and research purposes only. 3. Due to limited compilation skills, the translated article may not fully reflect the original text. Please refer to the original text for accuracy. 4. Regarding any domestic, Hong Kong, Macao, Taiwan, or international statements or positions, 2FIRSTS is fully aligned with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. Please contact us for removal if there are any infringements.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

UK HMRC Plans 30,000 Retail Enforcement Actions as Illegal Tobacco and Vape Sellers Face Tougher Crackdown
UK HMRC Plans 30,000 Retail Enforcement Actions as Illegal Tobacco and Vape Sellers Face Tougher Crackdown
The UK government has announced that HM Revenue & Customs (HMRC) will carry out more than 30,000 interventions targeting businesses and retail premises during the 2026-2027 financial year. The actions will focus on tax fraud, illegal goods sales and businesses involved in unlawful activities through retail channels. The government said illegal tobacco and illegal vape sales remain areas of concern. The move shows that UK enforcement against illegal nicotine products is expanding from import and supply channels toward retail-level oversight, alongside the upcoming introduction of the Vaping Products Duty.
Jul.24
Product | OXVA Launches ONEO Pro in France, Upgrading Its Open-Pod Platform
Product | OXVA Launches ONEO Pro in France, Upgrading Its Open-Pod Platform
Vape brand OXVA has introduced the ONEO Pro, a refillable open-pod system that entered the French market in July 2026. The device features a 2,100mAh battery, up to 40W output, a 4ml refillable cartridge, multiple coil options and a 0.96-inch color TFT display. The launch reflects continued performance upgrades within the refillable open-pod segment, with brands adding higher capacity, adjustable output and smarter device interaction.
Aug.03
CCPIT Says Trade Friction Index for China-Related Electronics Sector Remains High, With Vape Products Among Areas of Focus
CCPIT Says Trade Friction Index for China-Related Electronics Sector Remains High, With Vape Products Among Areas of Focus
China Council for the Promotion of International Trade (CCPIT) held its July regular press conference on July 31, 2026, releasing the May 2026 Global Economic and Trade Friction Index. CCPIT spokesperson Yang Fan said the global trade friction index stood at 95 in May, remaining at a medium-to-high level. By industry, the electronics sector recorded the highest trade friction index among 13 monitored industries. In China-related trade frictions, the index stood at 93, with electronics products including drones, chips and vape products among areas where friction remained elevated.
Aug.03
BAT New Categories Revenue Rises 18% in H1 2026 as Broad Portfolio Offers More Ways to Win—and Lose
BAT New Categories Revenue Rises 18% in H1 2026 as Broad Portfolio Offers More Ways to Win—and Lose
British American Tobacco’s New Category revenue rose 18% at constant rates in the first half of 2026. Nicotine-pouch brand Velo expanded rapidly, while Vuse recovered as U.S. enforcement against illicit e-vapor products strengthened. Heated-tobacco platform glo remained under pressure, and cigarettes continued to provide most of the group’s profit and cash. Compared with PMI and JT, BAT has more routes to growth—but also greater regulatory, investment and execution risks across its broader portfolio.
BAT
Jul.30
Data|China’s January-May 2026 Device Exports Rise 13% While Nicotine Product Exports Decline 6.9%
Data|China’s January-May 2026 Device Exports Rise 13% While Nicotine Product Exports Decline 6.9%
According to China Customs export data analyzed by 2Firsts, China’s vape export mix continued to evolve during January-May 2026. Exports of electronic vaporisation devices (HS 85434000) increased 13.00% year on year, supported by growth in both shipment volume and average export prices. Meanwhile, exports of nicotine-containing non-combustible products (HS 24041200) declined 6.89%, with lower shipment volumes partly offset by higher average export prices.
Special Report
Jun.30
PMI Oral Products Chief Says Lack of Rules May Push Nicotine Pouch Market Into Illicit Trade
PMI Oral Products Chief Says Lack of Rules May Push Nicotine Pouch Market Into Illicit Trade
Nick Ricketts, President of Oral Products at Philip Morris International (PMI), told Logos Press that nicotine pouches should be brought under clear regulatory frameworks covering nicotine limits, flavor rules, age verification, sales controls and marketing standards, arguing that the absence of clear rules or blanket bans may push consumer demand into illegal or semi-legal channels.
Jul.06